Fractyl Health Inc (GUTS) Cleared for RJVA-001 Trial. Let’s Look At Funding

Fractyl Health Inc (NASDAQ:GUTS) is one of billionaire Lee Ainslie’s stocks with huge upside potential. The stock has gained roughly 18% over the past month, and analysts see it surging 530% over the next 12 months.

On May 11, Fractyl Health Inc (NASDAQ:GUTS) announced that it has been cleared to go ahead with the planned Phase 1/2 trial of RJVA-001 in the Netherlands. RJVA-001 is a gene therapy candidate for treating type 2 diabetes, and it’s one of Fractyl Health’s leading programs.

Fractyl Health said the trial approval makes RJVA-001 the first gene therapy candidate for type 2 diabetes to enter clinical development. This study will assess the therapy’s safety and tolerability as the primary endpoints. Secondary endpoints include assessing the therapy’s preliminary efficacy.

Fractyl Health expects to dose the first patient with RJVA-001 and report preliminary data from the study in the second half of 2026. The company closed Q1 2026 with roughly $63.2 million in cash and cash equivalents. The management believes this cash position is adequate to fund operations into early 2027.

According to Fractyl Health, RJVA-001 could transform type 2 diabetes treatment. It’s designed to be a one-time treatment, as opposed to therapies that require chronic, high-dose systemic exposure.

Massachusetts-based Fractyl Health Inc (NASDAQ:GUTS) is a therapeutics company developing treatments for metabolic diseases. Its therapies are designed to address the root causes of obesity and type 2 diabetes. The company’s goal is to help prevent and reverse metabolic diseases.

While we acknowledge the risk and potential of GUTS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than GUTS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Data Center Stocks to Invest In According to Billionaires and 10 Best Debt-Free IT Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1